Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Brown, Morris"'
Autor:
Azizan EAB; Department of Medicine, Faculty of Medicine, The National University of Malaysia (UKM), Kuala Lumpur, Malaysia.; Endocrine Hypertension, Department of Clinical Pharmacology and Precision Medicine, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom., Drake WM; St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.; NIHR Barts Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Brown MJ; Endocrine Hypertension, Department of Clinical Pharmacology and Precision Medicine, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom. morris.brown@qmul.ac.uk.; NIHR Barts Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom. morris.brown@qmul.ac.uk.
Publikováno v:
Nature reviews. Nephrology [Nat Rev Nephrol] 2023 Dec; Vol. 19 (12), pp. 788-806. Date of Electronic Publication: 2023 Aug 23.
Autor:
Maniero C; From the Clinical Pharmacology Unit, Department of Medicine (C.M., S.G., J.Z.) and Medical Research Council Cancer Unit (T.I.J.), University of Cambridge, United Kingdom; Human Research Tissue Bank, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, United Kingdom (W.Z.); Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, United Kingdom (M.G.); and the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (J.Z., M.J.B.)., Garg S; From the Clinical Pharmacology Unit, Department of Medicine (C.M., S.G., J.Z.) and Medical Research Council Cancer Unit (T.I.J.), University of Cambridge, United Kingdom; Human Research Tissue Bank, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, United Kingdom (W.Z.); Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, United Kingdom (M.G.); and the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (J.Z., M.J.B.)., Zhao W; From the Clinical Pharmacology Unit, Department of Medicine (C.M., S.G., J.Z.) and Medical Research Council Cancer Unit (T.I.J.), University of Cambridge, United Kingdom; Human Research Tissue Bank, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, United Kingdom (W.Z.); Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, United Kingdom (M.G.); and the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (J.Z., M.J.B.)., Johnson TI; From the Clinical Pharmacology Unit, Department of Medicine (C.M., S.G., J.Z.) and Medical Research Council Cancer Unit (T.I.J.), University of Cambridge, United Kingdom; Human Research Tissue Bank, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, United Kingdom (W.Z.); Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, United Kingdom (M.G.); and the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (J.Z., M.J.B.)., Zhou J; From the Clinical Pharmacology Unit, Department of Medicine (C.M., S.G., J.Z.) and Medical Research Council Cancer Unit (T.I.J.), University of Cambridge, United Kingdom; Human Research Tissue Bank, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, United Kingdom (W.Z.); Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, United Kingdom (M.G.); and the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (J.Z., M.J.B.)., Gurnell M; From the Clinical Pharmacology Unit, Department of Medicine (C.M., S.G., J.Z.) and Medical Research Council Cancer Unit (T.I.J.), University of Cambridge, United Kingdom; Human Research Tissue Bank, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, United Kingdom (W.Z.); Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, United Kingdom (M.G.); and the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (J.Z., M.J.B.)., Brown MJ; From the Clinical Pharmacology Unit, Department of Medicine (C.M., S.G., J.Z.) and Medical Research Council Cancer Unit (T.I.J.), University of Cambridge, United Kingdom; Human Research Tissue Bank, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, United Kingdom (W.Z.); Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, United Kingdom (M.G.); and the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (J.Z., M.J.B.). morris.brown@qmul.ac.uk.
Publikováno v:
Hypertension (Dallas, Tex. : 1979) [Hypertension] 2017 Aug; Vol. 70 (2), pp. 357-364. Date of Electronic Publication: 2017 Jun 05.
Autor:
Tan GC; From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.)., Negro G; From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.)., Pinggera A; From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.)., Tizen Laim NMS; From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.)., Mohamed Rose I; From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.)., Ceral J; From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.)., Ryska A; From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.)., Chin LK; From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.)., Kamaruddin NA; From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.)., Mohd Mokhtar N; From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.)., A Jamal AR; From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.)., Sukor N; From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.)., Solar M; From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.)., Striessnig J; From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.)., Brown MJ; From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.)., Azizan EA; From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.). elena.azizan@ukm.edu.my.
Publikováno v:
Hypertension (Dallas, Tex. : 1979) [Hypertension] 2017 Jul; Vol. 70 (1), pp. 129-136. Date of Electronic Publication: 2017 Jun 05.
Autor:
Zhou J; From the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, United Kingdom (J.Z., M.J.B.); Clinical Pharmacology Unit, Department of Medicine, University of Cambridge (J.Z.), University of Cambridge Metabolic Research Laboratories, Wellcome Trust MRC Institute of Metabolic Science (B.L., G.S.H.Y.), Cambridge University Hospitals NHS Foundation Trust (S.G.N.), Addenbrooke's Hospital, United Kingdom; and Department of Medicine, Faculty of Medicine, The National University of Malaysia (UKM) Medical Centre, Kuala Lumpur (E.A.B.A.)., Lam B; From the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, United Kingdom (J.Z., M.J.B.); Clinical Pharmacology Unit, Department of Medicine, University of Cambridge (J.Z.), University of Cambridge Metabolic Research Laboratories, Wellcome Trust MRC Institute of Metabolic Science (B.L., G.S.H.Y.), Cambridge University Hospitals NHS Foundation Trust (S.G.N.), Addenbrooke's Hospital, United Kingdom; and Department of Medicine, Faculty of Medicine, The National University of Malaysia (UKM) Medical Centre, Kuala Lumpur (E.A.B.A.)., Neogi SG; From the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, United Kingdom (J.Z., M.J.B.); Clinical Pharmacology Unit, Department of Medicine, University of Cambridge (J.Z.), University of Cambridge Metabolic Research Laboratories, Wellcome Trust MRC Institute of Metabolic Science (B.L., G.S.H.Y.), Cambridge University Hospitals NHS Foundation Trust (S.G.N.), Addenbrooke's Hospital, United Kingdom; and Department of Medicine, Faculty of Medicine, The National University of Malaysia (UKM) Medical Centre, Kuala Lumpur (E.A.B.A.)., Yeo GS; From the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, United Kingdom (J.Z., M.J.B.); Clinical Pharmacology Unit, Department of Medicine, University of Cambridge (J.Z.), University of Cambridge Metabolic Research Laboratories, Wellcome Trust MRC Institute of Metabolic Science (B.L., G.S.H.Y.), Cambridge University Hospitals NHS Foundation Trust (S.G.N.), Addenbrooke's Hospital, United Kingdom; and Department of Medicine, Faculty of Medicine, The National University of Malaysia (UKM) Medical Centre, Kuala Lumpur (E.A.B.A.)., Azizan EA; From the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, United Kingdom (J.Z., M.J.B.); Clinical Pharmacology Unit, Department of Medicine, University of Cambridge (J.Z.), University of Cambridge Metabolic Research Laboratories, Wellcome Trust MRC Institute of Metabolic Science (B.L., G.S.H.Y.), Cambridge University Hospitals NHS Foundation Trust (S.G.N.), Addenbrooke's Hospital, United Kingdom; and Department of Medicine, Faculty of Medicine, The National University of Malaysia (UKM) Medical Centre, Kuala Lumpur (E.A.B.A.). elena.azizan@ukm.edu.my., Brown MJ; From the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, United Kingdom (J.Z., M.J.B.); Clinical Pharmacology Unit, Department of Medicine, University of Cambridge (J.Z.), University of Cambridge Metabolic Research Laboratories, Wellcome Trust MRC Institute of Metabolic Science (B.L., G.S.H.Y.), Cambridge University Hospitals NHS Foundation Trust (S.G.N.), Addenbrooke's Hospital, United Kingdom; and Department of Medicine, Faculty of Medicine, The National University of Malaysia (UKM) Medical Centre, Kuala Lumpur (E.A.B.A.).
Publikováno v:
Hypertension (Dallas, Tex. : 1979) [Hypertension] 2016 Dec; Vol. 68 (6), pp. 1424-1431. Date of Electronic Publication: 2016 Oct 24.
Publikováno v:
The New England journal of medicine [N Engl J Med] 2016 Apr 14; Vol. 374 (15), pp. 1494.
Autor:
Teo AE; From the Clinical Pharmacology Unit, Centre for Clinical Investigation, Addenbrooke's Hospital, University of Cambridge (A.E.D.T., S.G., L.H.S., J.Z., E.A.B.A., M.J.B.), Department of Medical Genetics, Division of Renal Medicine, University of Cambridge (F.E.K.F.), University of Cambridge Metabolic Research Laboratories, Wellcome Trust-Medical Research Council (MRC) Institute of Metabolic Science, Addenbrooke's Hospital (M.G.), Department of Pathology, Addenbrooke's Hospital (L.H., A.M.), and MRC Laboratory of Molecular Biology (M.B.) - all in Cambridge, United Kingdom; and the Department of Medicine, National University of Malaysia Medical Centre, Kuala Lumpur (E.A.B.A.)., Garg S, Shaikh LH, Zhou J, Karet Frankl FE, Gurnell M, Happerfield L, Marker A, Bienz M, Azizan EA, Brown MJ
Publikováno v:
The New England journal of medicine [N Engl J Med] 2015 Oct 08; Vol. 373 (15), pp. 1429-36. Date of Electronic Publication: 2015 Sep 23.
Autor:
Murthy M; Clinical Pharmacology Unit, Department of Medicine, Addenbrooke's Hospital, Cambridge, UK., Azizan EA, Brown MJ, O'Shaughnessy KM
Publikováno v:
Journal of hypertension [J Hypertens] 2012 Sep; Vol. 30 (9), pp. 1827-33.
Autor:
Azizan EA; Department of Clinical Pharmacology, University of Cambridge, Box 110, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, United Kingdom. eaba2@cam.ac.uk, Lam BY, Newhouse SJ, Zhou J, Kuc RE, Clarke J, Happerfield L, Marker A, Hoffman GJ, Brown MJ
Publikováno v:
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2012 May; Vol. 97 (5), pp. E819-29. Date of Electronic Publication: 2012 Mar 22.
Autor:
Azizan EA; Clinical Pharmacology Unit, Department of Medicine, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK., Murthy M, Stowasser M, Gordon R, Kowalski B, Xu S, Brown MJ, O'Shaughnessy KM
Publikováno v:
Hypertension (Dallas, Tex. : 1979) [Hypertension] 2012 Mar; Vol. 59 (3), pp. 587-91. Date of Electronic Publication: 2012 Jan 17.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.